Daniel J L, Molish I R, Rigmaiden M, Stewart G
J Biol Chem. 1984 Aug 10;259(15):9826-31.
When platelets were stimulated with ADP to cause shape change without aggregation or secretion, myosin 20,000-Da light chain phosphorylation was rapid and appeared to precede slightly the shape change response. While the shape of the platelets remained spheroidal, myosin phosphorylation was transient and after 2-5 min returned to the same level as that of unstimulated cells. Phosphorylation of the 47,000-Da platelet protein was minimal under these conditions. The phosphorylation time course was not altered by the addition of indomethacin or allowing the cells to aggregate. The dose-response curve of myosin phosphorylation very closely paralleled that of shape change with a midpoint at 0.7 microM ADP. ATP, a competitive antagonist of ADP, inhibited both shape change and myosin phosphorylation with the same concentration of ATP causing 50% inhibition of each response. Similarly, when platelets were stimulated with either 15-hydroxy-9,11-azo-prostadienoic acid or collagen, myosin phosphorylation slightly preceded shape change. These results suggest that myosin phosphorylation is required for the initial change in platelet shape but is not necessary for maintenance of the spherical shape.
当用二磷酸腺苷(ADP)刺激血小板使其发生形态改变而不发生聚集或分泌时,肌球蛋白20,000道尔顿轻链的磷酸化迅速发生,且似乎略先于形态改变反应。当血小板仍保持球形时,肌球蛋白的磷酸化是短暂的,2 - 5分钟后恢复到与未刺激细胞相同的水平。在这些条件下,47,000道尔顿血小板蛋白的磷酸化程度极低。添加吲哚美辛或使细胞聚集并不改变磷酸化的时间进程。肌球蛋白磷酸化的剂量反应曲线与形态改变的剂量反应曲线非常相似,中点为0.7微摩尔ADP。ATP作为ADP的竞争性拮抗剂,以相同浓度的ATP抑制形态改变和肌球蛋白磷酸化,导致每种反应50%的抑制。同样,当用15 - 羟基 - 9,11 - 偶氮 - 前列腺二烯酸或胶原刺激血小板时,肌球蛋白磷酸化略先于形态改变。这些结果表明,肌球蛋白磷酸化是血小板形态初始改变所必需的,但对于维持球形形态并非必要。